Can I Get an Epidural With Antithrombin Deficiency?
At a Glance
Women with antithrombin deficiency on blood thinners can typically get an epidural during labor, provided there is careful advance planning. Doctors must pause blood thinners for 12 to 24 hours before an epidural to prevent spinal bleeding, often requiring a scheduled induction.
In this answer
4 sections
Yes, women with antithrombin deficiency who are on blood thinners can usually get an epidural during labor, but it requires meticulous advance planning and strict medication timing. Because you are taking blood thinners to prevent life-threatening clots, your medical team must temporarily pause them to safely place the epidural needle in your back. Managing this delicate balance between clot prevention and spinal bleeding risk is complex, but with a specialized care plan, an epidural is a realistic and safe option for pain relief.
The Critical Timing of Blood Thinners
The biggest hurdle to getting an epidural while on a blood thinner like Low-Molecular-Weight Heparin (LMWH)—such as enoxaparin (Lovenox)—is timing. Placing an epidural too soon after your last dose carries a risk of a spinal epidural hematoma, which is bleeding around the spine. While this complication is incredibly rare when hospital protocols are followed, anesthesiologists take it very seriously because it can cause severe nerve damage [1][2].
To keep you safe, anesthesiologists follow strict waiting periods based on your medication dosage:
- Prophylactic (Low Dose): You typically must wait at least 12 hours after your last dose before an epidural can be placed [3].
- Therapeutic (High Dose): Because antithrombin deficiency is a high-risk condition, many patients are on higher, therapeutic doses of LMWH. In this case, you generally must wait at least 24 hours after your last dose [4][5].
The “Bridge” Strategy and Lab Testing
Because waiting 24 hours in spontaneous labor is unpredictable, doctors often use a “bridging” strategy. In the days leading up to delivery, they may switch you from LMWH to Unfractionated Heparin (UFH) [6][7].
UFH has a shorter half-life in the body, meaning it leaves your system faster. If you are switched to UFH, your waiting period will depend on how you take it:
- Subcutaneous (Injected) UFH: Usually requires a wait of up to 12 hours or more, depending on your dose [8].
- Intravenous (IV) UFH: Usually requires a wait of only 4 to 6 hours [8][9].
Regardless of which medication you use, your anesthesiologist will likely require a quick blood test (such as an aPTT or anti-Xa level) right before placing the epidural to confirm the blood thinner has adequately cleared your system [10][11].
The Role of Antithrombin Concentrate (ATc)
Antithrombin deficiency makes standard blood thinners less effective, a phenomenon known as heparin resistance [12][7]. To ensure your blood thinners work properly during the high-risk peripartum period (the time immediately before, during, and after birth), your doctors may administer Antithrombin Concentrate (ATc) via an IV [13][14].
ATc acts as a booster, restoring your body’s response to heparin and safely lowering your risk of developing a blood clot [15][16]. However, because ATc heavily potentiates (strengthens) the effect of the blood thinner, your care team must monitor your blood levels closely to avoid excessive bleeding [17][16].
Currently, receiving ATc does not change the standard 12- or 24-hour waiting rules for an epidural after LMWH [18]. However, the combination of these therapies means your anesthesiologist will carefully evaluate your individual bleeding risk before proceeding [18][19].
What If I Go Into Spontaneous Labor? (Plan B)
A common anxiety is: What if I go into labor right after taking my dose and absolutely cannot wait for an epidural?
If you arrive in rapid, spontaneous labor and your blood thinner hasn’t cleared, an epidural will not be safe. Your team will rely on a “Plan B” for pain management, which may include IV pain medications or nitrous oxide (laughing gas). If you require an emergency Cesarean section before your waiting period is up, your anesthesiologist will use general anesthesia (putting you to sleep) rather than a spinal block [9][20].
Why You Need a Pre-Delivery Consultation
To avoid emergencies, you need a coordinated delivery plan created weeks or months in advance by a multidisciplinary team. This team should include an obstetric anesthesiologist, a hematologist, and a maternal-fetal medicine (MFM) specialist [20][21].
During a pre-delivery consultation, your team will likely discuss:
- Scheduled Delivery: High-risk patients are often recommended for a scheduled induction of labor or a scheduled Cesarean section [9]. A scheduled delivery allows your doctors to perfectly time your last dose of blood thinners, the administration of ATc, and the placement of the epidural.
- Postpartum Care: You are still at an elevated risk of blood clots after delivery. Your team will plan exactly when to restart your blood thinners after the epidural catheter is safely removed, which can range from 4 to 24 hours later depending on your dose [22][23].
Common questions in this guide
How long do I have to wait for an epidural after taking my blood thinner?
What happens if I go into rapid labor right after taking my blood thinner?
Why might my doctor switch me to unfractionated heparin before I give birth?
Will getting antithrombin concentrate change when I can get my epidural?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Will I be transitioned from my current blood thinner to unfractionated heparin (UFH) as I approach my due date, and will it be via injection or IV?
- 2.What blood tests will the anesthesiologist require when I arrive in labor to confirm it is safe to place the epidural?
- 3.What are my specific 'Plan B' pain relief options if I go into rapid spontaneous labor and miss my epidural window?
- 4.How will you monitor my antithrombin levels during labor to determine if I need Antithrombin Concentrate (ATc)?
- 5.What is the exact timeline for safely restarting my blood thinners after I deliver, and who manages that order?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (23)
- 1
Neuraxial Anesthesia in Obstetric Patients Receiving Thromboprophylaxis With Unfractionated or Low-Molecular-Weight Heparin: A Systematic Review of Spinal Epidural Hematoma.
Leffert LR, Dubois HM, Butwick AJ, et al.
Anesthesia and analgesia 2017; (125(1)):223-231 doi:10.1213/ANE.0000000000002173.
PMID: 28628578 - 2
Neuraxial Techniques for Parturients with Thromboprophylaxis or Thrombocytopenia.
Galvan JM, Nixon HC
Anesthesiology clinics 2021; (39(4)):727-742 doi:10.1016/j.anclin.2021.08.011.
PMID: 34776106 - 3
Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition).
Kopp SL, Vandermeulen E, McBane RD, et al.
Regional anesthesia and pain medicine 2025; doi:10.1136/rapm-2024-105766.
PMID: 39880411 - 4
Residual Enoxaparin Activity, Anti-Xa Levels, and Concerns About the American Society of Regional Anesthesia and Pain Medicine Anticoagulation Guidelines.
Henshaw DS, Turner JD, Forest DJ, et al.
Regional anesthesia and pain medicine 2017; (42(4)):432-436 doi:10.1097/AAP.0000000000000617.
PMID: 28492441 - 5
Residual anti-Xa activity in plasma of patients presenting for electively planned neuraxial regional anesthesia.
Knoerlein J, Brodbeck P, Büchsel M, et al.
Regional anesthesia and pain medicine 2023; (48(5)):211-216 doi:10.1136/rapm-2022-104079.
PMID: 36707225 - 6
Management of antithrombin deficiency: an update for clinicians.
Bravo-Pérez C, Vicente V, Corral J
Expert review of hematology 2019; (12(6)):397-405 doi:10.1080/17474086.2019.1611424.
PMID: 31116611 - 7
Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study.
Abbattista M, Gianniello F, Novembrino C, et al.
The Lancet. Haematology 2020; (7(4)):e320-e328 doi:10.1016/S2352-3026(20)30007-7.
PMID: 32112716 - 8
ACOG Practice Bulletin No. 197: Inherited Thrombophilias in Pregnancy.
Obstetrics and gynecology 2018; (132(1)):e18-e34 doi:10.1097/AOG.0000000000002703.
PMID: 29939939 - 9
Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE-Position Paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH).
Hart C, Bauersachs R, Scholz U, et al.
Hamostaseologie 2020; (40(5)):572-590 doi:10.1055/a-1132-0750.
PMID: 32590872 - 10
Case report: A case of new mutation in SERPINC1 leading to thrombotic microangiopathy.
Li B, Zhang X, Lv H, et al.
Frontiers in genetics 2023; (14()):1278511 doi:10.3389/fgene.2023.1278511.
PMID: 37829283 - 11
Antimicrobial Prophylaxis and Anticoagulation Therapy in Pediatric ECMO: A Survey Study.
Frazier CA, Scott BM, Johnson PN, LaRochelle JM
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 2022; (27(1)):72-79 doi:10.5863/1551-6776-27.1.72.
PMID: 35002562 - 12
Severe antithrombin deficiency in pregnancy: Achieving adequate anticoagulation.
Pearson-Stuttard B, Bagot C, Ciantar E, et al.
Obstetric medicine 2019; (12(1)):45-51 doi:10.1177/1753495X17741025.
PMID: 30891093 - 13
Hereditary antithrombin III deficiency and neuraxial anaesthesia.
Piper BJ, Farrell PT
Anaesthesia and intensive care 2015; (43(6)):782-5 doi:10.1177/0310057X1504300618.
PMID: 26603805 - 14
Overcoming heparin resistance in pregnant women with antithrombin deficiency: a case report and review of the literature.
Tsikouras P, Christoforidou A, Bothou A, et al.
Journal of medical case reports 2018; (12(1)):169 doi:10.1186/s13256-018-1711-2.
PMID: 29907123 - 15
Effect of Exogenous Antithrombin Administration on Anti-Xa Levels in Infants Treated With Enoxaparin.
Logston BB, Rodman EA, Dinh KL, et al.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 2018; (23(4)):315-319 doi:10.5863/1551-6776-23.4.315.
PMID: 30181723 - 16
Issues in the Diagnosis and Management of Hereditary Antithrombin Deficiency.
Bauer KA, Nguyen-Cao TM, Spears JB
The Annals of pharmacotherapy 2016; (50(9)):758-67 doi:10.1177/1060028016651276.
PMID: 27281301 - 17
Exogenous supplementation of antithrombin III in adult and pediatric patients receiving extracorporeal membrane oxygenation.
Sorial MN, Greene RA, Zullo AR, et al.
The International journal of artificial organs 2020; (43(5)):315-322 doi:10.1177/0391398819888932.
PMID: 31750755 - 18
Antithrombin concentrate during pregnancy in congenital antithrombin deficiency: a single-center experience.
Bruzzese A, Santoro C, Baldacci E, et al.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2019; (30(6)):304-307 doi:10.1097/MBC.0000000000000835.
PMID: 31419212 - 19
Peripartum management of deep venous thrombosis in the context of antithrombin deficiency and May-Thurner syndrome.
Stevens-Haas CL, Livergood MC, Perez Botero J, McIntosh JJ
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2023; (34(3)):211-214 doi:10.1097/MBC.0000000000001183.
PMID: 36440804 - 20
Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis.
Croles FN, Nasserinejad K, Duvekot JJ, et al.
BMJ (Clinical research ed.) 2017; (359()):j4452 doi:10.1136/bmj.j4452.
PMID: 29074563 - 21
Prevention of thromboembolic events after radical prostatectomy in patients with hereditary thrombophilia due to a factor V Leiden mutation by multidisciplinary coagulation management.
Pose RM, Knipper S, Ekrutt J, et al.
Asian journal of urology 2024; (11(1)):42-47 doi:10.1016/j.ajur.2022.01.007.
PMID: 38312827 - 22
Practice advisory on the prevention and management of complications of pediatric regional anesthesia.
Ecoffey C, Bosenberg A, Lonnqvist PA, et al.
Journal of clinical anesthesia 2022; (79()):110725 doi:10.1016/j.jclinane.2022.110725.
PMID: 35313269 - 23
Time Is Bleeding Risk: A Case Report of Epidural Catheter Management in Two Patients Receiving Emergent Antithrombotic Therapy.
Murin P, Verma M, Sadeghipour H
A&A practice 2025; (19(3)):e01945 doi:10.1213/XAA.0000000000001945.
PMID: 40066893
This page is for informational purposes only and does not replace professional medical advice. Always consult your obstetrician, anesthesiologist, and hematologist about your specific delivery plan and medication timing.
Get notified when new evidence is published on Hereditary thrombophilia due to congenital antithrombin deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.